Back to Journals » Patient Preference and Adherence » Volume 9

Fear of driving license withdrawal in patients with insulin-treated diabetes mellitus negatively influences their decision to report severe hypoglycemic events to physicians

Authors Brož J, Brabec M, Janíčková Žďárská D, Fedáková Z, Hoskovcová L, You JY, Doničová V, Hlaďo P, Rahelić D, Kvapil M, Polák J

Received 26 April 2015

Accepted for publication 17 July 2015

Published 24 September 2015 Volume 2015:9 Pages 1367—1370

DOI https://doi.org/10.2147/PPA.S87393

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Doris Leung

Peer reviewer comments 2

Editor who approved publication: Dr Johnny Chen

Jan Brož,1 Marek Brabec,2,3 Denisa Janíčková Žďárská,1 Zuzana Fedáková,1 Lucie Hoskovcová,1 Jee Young You,4 Viera Doničová,5 Petr Hlaďo,6 Dario Rahelić,7 Milan Kvapil,1 Jan Polák8

1Department of Internal Medicine, Second Faculty of Medicine, Charles University, 2Institute of Computer Science of the Academy of Sciences of the Czech Republic, 3Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, 4Second Faculty of Medicine, Charles University, Prague, Czech Republic; 5Diabetes and Metabolism Center, Juh Polyclinic, Kosice, Slovakia; 6Institute of Lifelong Learning, Mendel University in Brno, Brno, Czech Republic; 7Department of Endocrinology, Diabetes and Metabolic Diseases, Dubrava University Hospital, Zagreb, Croatia; 8Center for Research on Diabetes, Metabolism and Nutrition, Second Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic

Background: Under current European Union legislation, two severe hypoglycemic events within 12 months is grounds for driving license withdrawal. The aim of the study reported here was to determine whether fear of such a withdrawal could lead to patients concealing severe hypoglycemia from physicians, which could negatively impact further treatment decisions.
Methods: A total of 663 patients with insulin-treated diabetes were anonymously surveyed about whether they would conceal severe hypoglycemic events from their physicians, if revealing them could result in driving license withdrawal. This investigation utilized an adapted and expanded questionnaire by Graveling et al.
Results: Of all diabetic patients surveyed, 26.17% would most likely not report hypoglycemia, and 25.86% were undecided. In a group of patients with type 1 diabetes, 31.83% would likely not report hypoglycemic events, and 25.06% were undecided. The patients least likely to report severe hypoglycemic events were those who indicated that vehicles were partly essential for work, and who also had more than two hypoglycemic events monthly.
Conclusion: A considerable percentage of diabetic patients would likely conceal severe hypoglycemic events from their physicians due to fear of driving license withdrawal. Patient failure to report severe hypoglycemic events can potentially lead to physicians being misinformed regarding the patient’s condition, which could lead to inadequate monitoring and treatment.

Keywords: hypoglycemia, education, law, type 1 diabetes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Depressed patients’ preferences for type of psychotherapy: a preliminary study

Yrondi A, Rieu J, Massip C, Bongard V, Schmitt L

Patient Preference and Adherence 2015, 9:1371-1374

Published Date: 24 September 2015

Hematuria following Botox treatment for upper limb spasticity: a case report

Lo TC, Yeung ST, Lee S, Chang EY

Journal of Pain Research 2015, 8:619-622

Published Date: 14 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010